Reversal is a real word for many people with Type 2 diabetes, and a misleading one for others. It is not a slogan. It is a specific clinical picture: HbA1c back in the non-diabetic range, fasting sugar in the calm zone, and (where the picture allows) life off long-term metformin or insulin. We see it often. We do not promise it. This post is the honest version of what we tell every patient who walks into our diabetes programme, including who is most likely to get there, what the labs say, and what the first ninety days actually look like.
What "reversal" even means
The word gets thrown around loosely. Let us be precise.
When we say reversal, we mean two things together. First, your HbA1c sits below 6.5 percent, and ideally below 6.0, without any glucose-lowering medication. Second, your fasting insulin and post-meal glucose look like a person whose body is no longer struggling. The diagnosis does not vanish from your record. The biology underneath it changes enough that you are no longer behaving, metabolically, like someone with diabetes.
There is a softer version of this called remission. The same numbers, but with the understanding that if you abandon the work, the numbers can drift back. We are honest with patients about this. The pancreas does not forget what it learned to do. But it also does not forget what wore it down.
What reversal is not: a one-time cleanse, a powder, a fourteen-day fix, or a guarantee. Anyone selling you that is selling you a story.
The Beyond Meds thesis, said plainly: the goal is to move you off long-term metformin, insulin, and statins where the clinical picture allows. Short-term medication during the programme is expected. We are not anti-medicine. We are anti the assumption that you must be on these tablets for life by default.
The pancreas does not forget what it learned to do. It also does not forget what wore it down.
Who is more likely to get there
Some patients reverse fully. Some get a meaningful drop in HbA1c and dose. Some hold the line and stop progressing. All three are wins. Pretending the first one is the only success is dishonest.
In our experience, the patients who reverse fully tend to share some features. None of these are deal-breakers on their own.
Shorter duration of diabetes helps. If you were diagnosed in the last five years, your beta cells (the insulin-making cells in your pancreas) are usually still doing real work. If you were diagnosed twenty years ago and are now on insulin, you can still get healthier, but full reversal is less likely.
Insulin resistance, not insulin deficiency, is the main story. Most Indians with Type 2 are insulin resistant first and insulin deficient much later. If your fasting insulin is high, your C-peptide is healthy, and your beta cells are still firing, you are in a good window.
A real visceral fat load that has not yet hardened into long-term complications. Fatty liver, a thick waistline, and a high triglyceride to HDL ratio all point to a metabolism that has been pushed, not broken.
Sleep that can be repaired. Stress that can be turned down. A life where, with planning, you can eat differently for ninety days. None of this requires perfection. It requires room.
The patients who do not fully reverse, but still get real value, tend to be longer-duration diabetics, those on multiple insulin injections, and those with very low C-peptide. For them, the goal shifts. Lower dose. Better numbers. Fewer complications down the line. Off the statin. Off the BP tablet, if the picture allows.
What this looks like in practice
Three real arcs. Names changed.
Pradeep, 52, came in with HbA1c 8.4, on metformin 1000 mg twice a day, and a fatty liver his last scan had quietly noted. He had been told his diabetes was "moderate" and he should brace for insulin within five years. Six months in, his HbA1c was 5.9, his fasting insulin had dropped, and he was off metformin entirely. The thing that mattered most for him was not a single supplement. It was a real evening meal, before sunset, that did not contain rice.
Ritu, 47, walked in already on basal insulin, 30 units at night, plus two oral tablets. Her energy was flat. Her sleep was wrecked. Her morning sugars sat at 180. We did not chase the insulin first. We chased the sleep, the cortisol pattern, the gut, and the meal sequencing. By month four she was off insulin entirely, on a much lower dose of one oral, and her morning sugars were in the 90s. Her words: "main bhool gayi thi ki main thakti nahi thi" (I had forgotten that I used to not be tired).
Sandeep, 41, came in for fatty liver, not diabetes, with a fasting sugar of 112 and a HbA1c of 6.2. Pre-diabetic, not yet diabetic. His ALT was 78. His triglyceride to HDL ratio was 4.2. We are biased about cases like Sandeep because they are the easiest. In four months, his liver enzymes were normal, his HbA1c was 5.4, and his ratio was 1.6. He never needed metformin. He probably never will, if he keeps the basics.
These three are not unusual. They are also not the only kind of story. Some patients drop two points on HbA1c and that is the whole arc. Some halve their insulin and stop there. We count those as wins too.
The labs that matter (and the ones that don't)
Most diabetic patients in India are followed with three numbers: fasting sugar, post-meal sugar, and HbA1c. These are useful. They are also, on their own, not enough to tell you what is actually happening.
The labs we add, and the reasons.
Fasting insulin. This is the single most underused test in Indian diabetes care. HbA1c tells you what your sugar has averaged. Fasting insulin tells you how hard your pancreas had to work to get there. Two patients can have the same HbA1c with very different stories underneath.
HOMA-IR. A simple calculation from fasting glucose and fasting insulin. It estimates insulin resistance. We track it through the programme.
C-peptide. Tells us whether your beta cells are still producing well. Important if we are thinking about coming off insulin.
Triglyceride to HDL ratio. A quick and brutal proxy for metabolic health. In Indian patients, a ratio above 3 is a flag. Above 4, we treat it as urgent. It often drops faster than HbA1c does.
ALT, AST, GGT. Liver enzymes. If your liver is fatty, your insulin resistance lives there. Reverse the liver, and the rest follows.
Vitamin D, B12, ferritin, TSH, free T3, free T4. Cofactors that decide whether your metabolism has the raw material to do its job. Most of our diabetic patients walk in deficient in at least two of these.
hsCRP. A marker of low-grade inflammation. Insulin resistance and inflammation travel together.
What we do not over-rely on: a single random sugar reading, a glucometer reading taken on a stressful morning, or a HbA1c that has been sitting at the same number for three years and is now treated as "controlled." Controlled is not the same as well.
For more on the upstream story behind these numbers, insulin resistance is the silent driver of most of what shows up later.
HbA1c tells you what your sugar averaged. Fasting insulin tells you how hard your pancreas had to work to get there.
Why metformin alone won't get you off metformin
Metformin is a useful tablet. It lowers hepatic glucose output. It is well-studied. It is inexpensive. We are not against it.
Here is the problem. Metformin does not address why your liver is making too much glucose in the first place. It does not fix the visceral fat. It does not fix the sleep. It does not fix the chronic stress that keeps your cortisol climbing at three in the morning. It does not fix the gut inflammation that is driving systemic inflammation that is driving insulin resistance.
So metformin keeps the number in range. The underlying story keeps moving. Five years later, one tablet becomes two. Ten years later, two becomes a basal insulin. Fifteen years later, the conversation is about complications, not reversal.
This is not a failure of the medicine. It is a failure of asking the medicine to do something it was never designed to do.
The work of reversal is the work the medicine cannot do. Food sequencing. Walking after meals. Real sleep. Stress that has somewhere to land. Specific micronutrients corrected. Gut healed where it needs healing. The liver de-fatted. Once those are happening, the medicine has less to do, and the dose can come down with care.
The Root Method is the structure we use to do this systematically rather than as a list of healthy intentions.
A 90-day arc, in plain language
This is not a script. Patients vary. But the arc is real and it is worth knowing what to expect.
Weeks 1 to 2. We test thoroughly. We map your day. We start changing what you eat at dinner first, because dinner is where most of the damage happens in Indian households. We start a short walk after each meal. We adjust your sleep window. We do not change your medication yet.
Weeks 3 to 6. Energy starts shifting. Most patients report less afternoon slump, fewer cravings, calmer mornings. Fasting sugars often start moving down by week four. If they move down sharply, this is when we begin tapering metformin or basal insulin, slowly, with daily glucometer readings to keep us honest.
Weeks 7 to 9. The harder layers come up. The liver is being asked to clear out. Sleep usually deepens. We add the targeted gut and inflammation work that the early weeks set up. Triglyceride to HDL ratios usually move first. HbA1c will not have caught up yet.
Weeks 10 to 12. Repeat labs. This is the first honest checkpoint. Most patients see HbA1c down by 1 to 2 points. Fasting insulin down. Liver enzymes down. We make the next round of decisions about medication based on the actual numbers, not on hope.
What ninety days does not always do: take a fifteen-year diabetic with low C-peptide off insulin entirely. What it does do: give us a clear picture of what your biology can and cannot do, and where the next ninety days should go.
The structured ninety-day arc is what we run inside the Elixir programme.
When reversal isn't on the table, what is
Some patients will not fully reverse. We say this in the first conversation, not the last.
If you have had diabetes for over fifteen years, are on multiple insulin injections, and have a low C-peptide, your beta cells are tired. They will not magically rebuild. What we can do is real, and it matters.
Lower your insulin dose, often substantially.
Get you off the oral tablets that are no longer earning their place.
Address the things that turn diabetes into complications: the high blood pressure, the climbing cholesterol, the fatty liver, the kidney stress, the neuropathy that is just starting in your feet.
Get your sleep back. Get your energy back. Get your mood back. These are not soft outcomes. They are the difference between living with diabetes and being defined by it.
Pull you off the long-term statin where the lipid picture allows. Pull you off the long-term BP tablet where the pressure picture allows. Keep the short-term medication that the current biology genuinely needs.
For some of you, "off all chronic medication" is the honest goal. For some of you, "on the smallest dose, with the best numbers, with the lowest complication risk" is the honest goal. Both are root-cause work. Neither is a failure.
You can read more about how we frame the metabolic side of this on the diabetes and insulin resistance page, and the sleep and hormone connection that quietly decides how well any of the above lands.
